Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,764 | 14,031 | 71,560 | 91,297 | 0 |
| Marketable Securities | 245,238 | 328,034 | 95,209 | 36,679 | 0 |
| Receivables | 11,599 | 12,667 | 476 | N/A | 0 |
| Income taxes - deferred | N/A | N/A | N/A | 1,246 | N/A |
| TOTAL | $337,329 | $359,546 | $169,747 | $130,144 | $0 |
| Non-Current Assets | |||||
| PPE Net | 23,220 | 6,386 | 3,758 | 3,565 | 0 |
| Investments And Advances | 58,905 | 125,382 | 27,125 | 0 | 0 |
| Other Non-Current Assets | 611 | 590 | 575 | 3,299 | 0 |
| TOTAL | $82,736 | $132,358 | $31,458 | $6,864 | $N/A |
| Total Assets | $420,065 | $491,904 | $201,205 | $137,008 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,748 | 11,067 | 3,678 | 3,308 | 0 |
| Accrued Expenses | 15,996 | 14,020 | 6,586 | 1,708 | 0 |
| Other current liabilities | N/A | 6 | 9 | 65 | 0 |
| TOTAL | $52,888 | $61,089 | $36,930 | $35,113 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 22,144 | 35,996 | 25,195 | 25,157 | N/A |
| Other Non-Current Liabilities | 0 | 0 | 6 | 15 | 0 |
| TOTAL | $22,059 | $6,449 | $32,793 | $57,997 | $N/A |
| Total Liabilities | $74,947 | $67,538 | $69,723 | $93,110 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,851 | 37,218 | 31,590 | N/A | N/A |
| Common Shares | 38 | 37 | 31 | 3 | 0 |
| Retained earnings | -284,680 | -166,948 | -113,444 | -74,037 | 0 |
| Other shareholders' equity | -318 | -57 | 14 | 115,920 | 0 |
| TOTAL | $345,118 | $424,366 | $131,482 | $43,898 | $0 |
| Total Liabilities And Equity | $420,065 | $491,904 | $201,205 | $137,008 | $0 |